Loading the security page…
The series is stated in the current share scale after splits; dividends are not included in the price
Vir Biotechnology, Inc. (VIR) is a public company in the healthcare sector. Its common stock trade on NASDAQ.
Over the trailing twelve months as reported to 2026-06-30, revenue was 303.2m $, net income was -251.7m $. Incorporated in US.
This summary is compiled automatically from SEC filings and exchange data.
Based on the last 12 months of reports, through 30 June 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Vir Biotechnology, Inc. (VIR) is a company in the Health care sector; its shares trade on Nasdaq.
The price of Vir Biotechnology, Inc. (VIR) on October 30, 2026 is 11.33 $, −3.57 % on the day. Over 52 weeks the stock traded between 4.82 $ and 12.00 $; the price now sits 91 % of the way up that range. Over the past year the price changed by +72.49 %. Market capitalization is 1.92 billion $, rank 32 among 132 stocks of the same industry with a known capitalization.
Vir Biotechnology, Inc. trades on Nasdaq under the ticker VIR. The company belongs to the Health care sector. The trading history on this page starts on 11 October 2019.
Over the past 52 weeks VIR has traded between 4.82 $ and 12.00 $. As of 30 October 2026 the price stood 78.71 % of the way from the 52-week low to the high.
Over one year VIR shares rose 72.49 %; over six months they rose 1.36 %. Volatility over 90 days is 49.86 %. Dividends are not included: this is price change only, as of 30 October 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to sales is 6.3, above the sector median of 3.6. Price to book is 2.0, below the sector median of 2.5. Calculated from reports for the period ending 30 June 2026.
Vir Biotechnology, Inc. reported revenue of 303M $ and a net loss of 252M $ over the last four quarters. Net margin is −83.00 %. Revenue changed by +1,495.93 % year over year. Earnings per share are −1.77 $. Market capitalisation is 1.9B $.
VIR has a return on equity of −25.62 %, above the sector median of −40.58 %. Return on assets is −20.72 %, above the sector median of −30.08 %. Operating margin is −92.40 %, below the sector median of −20.96 %.